Adherence to adding inhaled corticosteroids to rescue therapy in a pragmatic trial with adults with asthma: A pilot study

Juan Carlos Cardet, Paula J. Busse, Jennifer K. Carroll, Thomas B. Casale, Tamera Coyne-Beasley, Sherrie Dixon-Williams, Maureen Fagan, Victoria E. Forth, Anne L. Fuhlbrigge, Michelle L. Hernandez, David Kaelber, Barbara Kaplan, Margarita Lorenzi, Suzanne Madison, Nancy E. Maher, Karen Majewski, Brian Manning, Melissa D. McKee, Sylvette Nazario, Wilson D. PaceMichael J. Pencina, Cynthia S. Rand, Jacqueline Rodriguez-Louis, Lilin She, Joel Shields, Jessica E. Teng, Michael E. Wechsler, Juan P. Wisnivesky, Barbara P. Yawn, Elliot Israel

Research output: Contribution to journalArticle

Abstract

Background: Underuse of guideline-recommended inhaled corticosteroids (ICS) controller therapy is a risk factor for greater asthma burden. ICS concomitantly used with rescue inhalers (Patient-Activated Reliever-Triggered ICS [‘PARTICS’]) reduced asthma exacerbations in efficacy trials, but whether PARTICS is effective in pragmatic trials is unknown. Objective: We conducted this pilot to determine the feasibility of executing a large-scale pragmatic PARTICS trial and to improve study protocols. Methods: Four sites recruited 33 Hispanic or black adults with persistent asthma, randomized them approximately 3:1 to intervention or usual care, and followed them for 12 weeks. All participants received asthma guideline-based educational videos; intervention participants received video-based instructions on implementing PARTICS plus usual medications. The study involved 1 randomization visit and monthly questionnaires. Timely questionnaire responses (±2 weeks) were monitored. Participants underwent qualitative phone interviews to assess self-reported adherence to PARTICS and understand barriers to completing study procedures. Results: Timely questionnaire response rates were 61%, 64%, and 70% at 4, 8, and 12 weeks, respectively. Self-reported adherence to PARTICS was 76% (95% confidence interval [CI], 58%-94% [n = 21]), 88% (95%CI, 72%-100% [n = 16]), and 62% (95%CI, 36%-88% [n = 13]) at weeks 1, 6, and 12, respectively. Barriers to completing study procedures included difficulties with questionnaire access, remembering to use ICS and rescue inhalers together, and obtaining refills. Only 22% of participants recognized their short-acting bronchodilator as “reliever” or “rescue.” Conclusion: Recruitment was feasible within the allocated period. Adherence to PARTICS was incomplete, questionnaire completion was suboptimal, and common rescue inhaler nomenclature usage was limited. We have modified the full study protocol to attempt to improve adherence to PARTICS and minimize barriers to study procedures. Clinical trials registration: pilot study for ‘PeRson EmPowered Asthma Relief’ (PREPARE, NCT02995733)

Original languageEnglish (US)
Pages (from-to)487-493.e1
JournalAnnals of Allergy, Asthma and Immunology
Volume124
Issue number5
DOIs
StatePublished - May 2020

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Adherence to adding inhaled corticosteroids to rescue therapy in a pragmatic trial with adults with asthma: A pilot study'. Together they form a unique fingerprint.

  • Cite this

    Cardet, J. C., Busse, P. J., Carroll, J. K., Casale, T. B., Coyne-Beasley, T., Dixon-Williams, S., Fagan, M., Forth, V. E., Fuhlbrigge, A. L., Hernandez, M. L., Kaelber, D., Kaplan, B., Lorenzi, M., Madison, S., Maher, N. E., Majewski, K., Manning, B., McKee, M. D., Nazario, S., ... Israel, E. (2020). Adherence to adding inhaled corticosteroids to rescue therapy in a pragmatic trial with adults with asthma: A pilot study. Annals of Allergy, Asthma and Immunology, 124(5), 487-493.e1. https://doi.org/10.1016/j.anai.2019.12.027